Insider Trades of BAY CITY CAPITAL LLC Information

Click on the column header to resort ascending (▲) or descending (▼).

Individual Insider Trades

Company Relation Last Date ▲ Type Tran OwnerType Shares Traded Last Price Shares Held
EPIZYME, INC. Beneficial Owner (10%) 06/05/2013 Form 4 Acquisition (Non Open Market) indirect 3,492,063 0 3,492,063
EPIZYME, INC. Beneficial Owner (10%) 06/05/2013 Form 4 Buy indirect 166,666 15 7,314,341
EPIZYME, INC. Beneficial Owner (10%) 02/10/2014 Form 4 Sell indirect 466,667 29.25 6,392,851
SUNESIS PHARMACEUTICALS INC Beneficial Owner (10%) 08/08/2014 Form 4 Sell direct 675,000 6.6201 4,963,087
SUNESIS PHARMACEUTICALS INC Beneficial Owner (10%) 08/11/2014 Form 4 Sell direct 31,600 6.902 4,931,487
SUNESIS PHARMACEUTICALS INC Beneficial Owner (10%) 08/12/2014 Form 4 Sell direct 37,100 6.7717 4,894,387
EPIZYME, INC. Beneficial Owner (10%) 08/21/2014 Form 4 Sell indirect 38,666 33.0352 3,153,396
EPIZYME, INC. Beneficial Owner (10%) 08/22/2014 Form 4 Sell indirect 128,000 32.4591 3,025,396
EPIZYME, INC. Beneficial Owner (10%) 08/25/2014 Form 4 Sell indirect 200,000 35.1333 5,650,809
EPIZYME, INC. Beneficial Owner (10%) 08/26/2014 Form 4 Sell indirect 200,000 35.139 5,654,532
SUNESIS PHARMACEUTICALS INC Beneficial Owner (10%) 08/27/2014 Form 4 Sell direct 100,700 8.163 4,793,687
SUNESIS PHARMACEUTICALS INC Beneficial Owner (10%) 08/28/2014 Form 4 Sell direct 200,000 7.8851 4,593,687
DERMIRA, INC. Director 10/08/2014 Form 4 Acquisition (Non Open Market) indirect 3,420,295 0 3,373,255
DERMIRA, INC. Director 10/08/2014 Form 4 Buy indirect 69,112 16 3,506,647
NEVRO CORP Other 11/12/2014 Form 4 Acquisition (Non Open Market) indirect 2,193,257 0 2,217,214
INTERLEUKIN GENETICS INC Beneficial Owner (10%) 12/23/2014 Form 4 Buy indirect 26,491,952 0.1003 47,064,115